As advocates for improving access, affordability, and outcomes, Evernorth Health Services is taking on some of the biggest challenges in the health care industry, including rising costs and fragmented...

The team focuses on highly complex medications, including treatments for cancer, neurological diseases, pulmonary conditions, and bleeding disorders.

Growing demand and new regulations have put the onus on plan sponsors to prioritize the need for a comprehensive home infusion strategy.

Regulatory pressures and technological advancements are changing utilization management as we know it—here’s what plan sponsors should know.

Over 125 million Americans suffer from chronic conditions, costing the U.S. over $3.4 trillion annually. This topic was the focus of a breakout session at Outcomes+ 2022.

Drug formularies are critical to combat the estimated $16 billion wasted each year on low value drugs that do not improve health outcomes.

Breaking down the challenges, therapies and costs associated with hemophilia.

The first interchangeable biosimilar is now available. Here’s what plans need to know about these products, which – like generics – can be substituted at the pharmacy.